My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 341

    1.

    Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding--a European perspective.

    Vincent JL, Rossaint R, Riou B, Ozier Y, Zideman D, Spahn DR.

    Crit Care. 2006;10(4):R120.PMID: 16919168 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.

    Martinowitz U, Michaelson M; Israeli Multidisciplinary rFVIIa Task Force.

    J Thromb Haemost. 2005 Apr;3(4):640-8.PMID: 15842347 [PubMed - indexed for MEDLINE]Related articles

    3.

    Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.

    Martinowitz U, Kenet G, Lubetski A, Luboshitz J, Segal E.

    Can J Anaesth. 2002 Dec;49(10):S15-20.PMID: 12546003 [PubMed - indexed for MEDLINE]Related articles

    4.

    Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.

    Brenner B, Wiis J.

    Hematology. 2007 Feb;12(1):55-62.PMID: 17364994 [PubMed - indexed for MEDLINE]Related articles

    5.

    An evaluation of eptacog alfa in nonhaemophiliac conditions.

    Mallarkey G, Brighton T, Thomson A, Kaye K, Seale P, Gazarian M.

    Drugs. 2008;68(12):1665-89. Review.PMID: 18681490 [PubMed - indexed for MEDLINE]Related articles

    6.

    Recombinant factor VIIa in the treatment of non-hemophiliac bleeding.

    Lam MS, Sims-McCallum RP.

    Ann Pharmacother. 2005 May;39(5):885-91. Epub 2005 Mar 22. Review.PMID: 15784806 [PubMed - indexed for MEDLINE]Related articles

    7.

    Control of bleeding in children with Dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study.

    Chuansumrit A, Wangruangsatid S, Lektrakul Y, Chua MN, Zeta Capeding MR, Bech OM; Dengue Study Group.

    Blood Coagul Fibrinolysis. 2005 Nov;16(8):549-55.PMID: 16269927 [PubMed - indexed for MEDLINE]Related articles

    8.

    Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings.

    Grounds RM, Bolan C.

    Crit Care. 2005;9 Suppl 5:S29-36. Epub 2005 Oct 7. Review. Erratum in: Crit Care. 2005;9(6):560. PMID: 16221317 [PubMed - indexed for MEDLINE]Related articles

    9.

    The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.

    Pychyńska-Pokorska M, Moll JJ, Krajewski W, Jarosik P.

    Pediatr Crit Care Med. 2004 May;5(3):246-50.PMID: 15115562 [PubMed - indexed for MEDLINE]Related articles

    10.

    The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma.

    Geeraedts LM Jr, Kamphuisen PW, Kaasjager HA, Verwiel JM, van Vugt AB, Frölke JP.

    Injury. 2005 Apr;36(4):495-500. Epub 2004 Dec 8.PMID: 15755430 [PubMed - indexed for MEDLINE]Related articles

    11.

    Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.

    Mayo A, Misgav M, Kluger Y, Geenberg R, Pauzner D, Klausner J, Ben-Tal O.

    Vox Sang. 2004 Jul;87(1):34-40. Review.PMID: 15260820 [PubMed - indexed for MEDLINE]Related articles

    12.

    Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials.

    Boffard KD, Riou B, Warren B, Choong PI, Rizoli S, Rossaint R, Axelsen M, Kluger Y; NovoSeven Trauma Study Group.

    J Trauma. 2005 Jul;59(1):8-15; discussion 15-8.PMID: 16096533 [PubMed - indexed for MEDLINE]Related articles

    13.

    Use of recombinant activated factor VII for bleeding in pancreatitis: a case series.

    Laffan MA, Tait RC, Blatný J, Espersen K, Grabowska I, Loch-Bakoñska L, Pauzkowska A, Stasiak-Pikula E, Michalska G, Wendon J, Piotrowska K.

    Pancreas. 2005 Apr;30(3):279-84.PMID: 15782108 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Activated recombinant factor VII (Novoseven) in multiple trauma patients: an outcome analysis]

    Grinţescu I, Tulbure D, Mirea L.

    Chirurgia (Bucur). 2006 Nov-Dec;101(6):615-24. Romanian. PMID: 17283837 [PubMed - indexed for MEDLINE]Related articles

    15.

    Recombinant activated coagulation factor VII and bleeding trauma patients.

    Rizoli SB, Nascimento B Jr, Osman F, Netto FS, Kiss A, Callum J, Brenneman FD, Tremblay L, Tien HC.

    J Trauma. 2006 Dec;61(6):1419-25.PMID: 17159685 [PubMed - indexed for MEDLINE]Related articles

    16.

    Efficacy and safety of recombinant activated factor VII to control bleeding in nonhemophiliac patients: a review of 17 randomized controlled trials.

    Hardy JF, Bélisle S, Van der Linden P.

    Ann Thorac Surg. 2008 Sep;86(3):1038-48. Review.PMID: 18721620 [PubMed - indexed for MEDLINE]Related articles

    17.

    "Off-license" use of recombinant activated factor VII.

    Ghorashian S, Hunt BJ.

    Blood Rev. 2004 Dec;18(4):245-59. Review.PMID: 15501553 [PubMed - indexed for MEDLINE]Related articles

    18.

    Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial.

    Bosch J, Thabut D, Albillos A, Carbonell N, Spicak J, Massard J, D'Amico G, Lebrec D, de Franchis R, Fabricius S, Cai Y, Bendtsen F; International Study Group on rFVIIa in UGI Hemorrhage.

    Hepatology. 2008 May;47(5):1604-14.PMID: 18393319 [PubMed - indexed for MEDLINE]Related articles

    19.

    Off-label use of recombinant factor VIIa for treatment of haemorrhage: results from randomized clinical trials.

    Johansson PI.

    Vox Sang. 2008 Jul;95(1):1-7. Epub 2008 Apr 23. Review.PMID: 18435677 [PubMed - indexed for MEDLINE]Related articles

    20.

    A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.

    Murkin JM.

    Can J Anaesth. 2002 Dec;49(10):S21-6. Review.PMID: 12546007 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity